e-learning
resources
Berlin 2008
Monday, 06.10.2008
Diagnostic aspects in thoracic oncology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of alveolar-capillary permeability of lung cancer patients
N. Krivonogov, T. Ageeva, S. Avdeev, A. Zav‘yalov, A. Dubodelova, E. Dubodelov, N. Dem‘yanenko, S. Mishustin (Tomsk, Russian Federation)
Source:
Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Session:
Diagnostic aspects in thoracic oncology
Session type:
Thematic Poster Session
Number:
2617
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Krivonogov, T. Ageeva, S. Avdeev, A. Zav‘yalov, A. Dubodelova, E. Dubodelov, N. Dem‘yanenko, S. Mishustin (Tomsk, Russian Federation). Evaluation of alveolar-capillary permeability of lung cancer patients. Eur Respir J 2008; 32: Suppl. 52, 2617
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Assessment of lipid peroxidation and antioxidant capacity in pulmonary parenchyma and lung cancer tissue in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 79s
Year: 2004
Assessment of lung epithelial permeability by
99m
Tc-DTPA and its relation to pulmonary functions in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 495s
Year: 2001
Pulmonary function testing in patients with lung cancer
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012
Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
CXCL5-dependent neutrophil recruitment harms lung barrier function in acute lung injury
Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels
Year: 2018
Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort
Source: Eur Respir J, 49 (5) 1601162; 10.1183/13993003.01162-2016
Year: 2017
Lung compliance in patients with pulmonary fibrosis with normal lung volumes
Source: Eur Respir J 2007; 30: Suppl. 51, 577s
Year: 2007
Effect of prior statin therapy on capillary permeability in the lungs after cardiac or vascular surgery
Source: Eur Respir J 2006; 27: 1026-1032
Year: 2006
Prediction of efficacy of inhaled steroid on COPD by alveolar-capillary membrane permeability
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009
Influence of the lung resection to small airways function in patients with limited and normal lung function and primary non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 718s
Year: 2006
Outcome of treated advanced non-small cell lung cancer associated with central airway obstruction
Source: Eur Respir J 2006; 28: Suppl. 50, 796s
Year: 2006
Changes in the pulmonary microbiome associated with lung cancer
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
The lung microcirculation changes in patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 407s
Year: 2006
Lung cancer and interstitial lung disease
Source: International Congress 2018 – State of the art session: Thoracic oncology
Year: 2018
The association of lung cancer with pulmonary fibrosis
Source: ERJ Open Res, 8 (1) 00505-2021; 10.1183/23120541.00505-2021
Year: 2022
Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009
A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Management of concomitant COPD in patients with lung cancer
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept